Please use this identifier to cite or link to this item: http://hdl.handle.net/11434/748
Full metadata record
DC FieldValueLanguage
dc.contributor.authorSinclair, Rodney-
dc.contributor.otherEllis, J.-
dc.date2008-07-
dc.date.accessioned2016-08-30T04:34:36Z-
dc.date.available2016-08-30T04:34:36Z-
dc.date.issued2008-09-
dc.identifier.citationDrug Discov Today. 2008 Sep;13(17-18):791-7.en_US
dc.identifier.issn1359-6446en_US
dc.identifier.urihttp://hdl.handle.net/11434/748-
dc.description.abstractMale pattern baldness affects up to half of the male Caucasian population by middle age, and almost all Caucasian men by old age. Especially in younger men, this heritable form of hair loss can have significant psycho-social consequences. Although approved pharmacological agents exist to manage the condition, none of the currently available options are highly efficacious. New treatments under development, and acceleration in our understanding of the underlying molecular genetic aetiology of this condition provide increased hope for future targeted treatment strategies.en_US
dc.publisherElsevieren_US
dc.subjectAgeden_US
dc.subjectAlopeciaen_US
dc.subjectAetiologyen_US
dc.subjectGeneticsen_US
dc.subjectPhysiopathologyen_US
dc.subjectTherapyen_US
dc.subjectMaleen_US
dc.subjectMiddle Ageden_US
dc.subjectMale Pattern Baldnessen_US
dc.subjectHead & Neck Clinical Institute, Epworth HealthCareen_US
dc.subjectChair of Dermatology, Epworth HealthCareen_US
dc.titleMale pattern baldness: current treatments, future prospects.en_US
dc.typeJournal Articleen_US
dc.identifier.doi10.1016/j.drudis.2008.05.010en_US
dc.identifier.journaltitleDrug Discovery Todayen_US
dc.description.pubmedurihttp://www.ncbi.nlm.nih.gov/pubmed/18617016en_US
dc.description.affiliatesDepartment of Physiology, University of Melbourne, Victoria, Australiaen_US
dc.type.studyortrialReviewen_US
dc.type.contenttypeTexten_US
Appears in Collections:Dermatology
Head & Neck

Files in This Item:
There are no files associated with this item.


Items in Epworth are protected by copyright, with all rights reserved, unless otherwise indicated.